AMRN Q1 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+26.8% YoY

Gross Profit

$33M75.8% margin

Operating Income

-$22M-49.9% margin

Net Income

-$24M-54.9% margin

EPS (Diluted)

$-1.69

QoQ Revenue Growth

-18.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$216M

Total Liabilities

$232M

Stockholders' Equity

-$17M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$35M	+26.8%
Gross Profit	$33M	$26M	+25.8%
Operating Income	-$22M	-$19M	-18.0%
Net Income	-$24M	-$21M	-15.1%